Healthcare
Live Price
Offline$0.00005
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → May 22, 2026
Coverage: 227 bars · Jun 23, 2025 → May 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PPJ Healthcare Enterprises, Inc. (PPJE) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → May 22, 2026). Baseline metrics include revenue growth of -6.4%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue -6.4%, EPS 0.0%, free cash flow -3.6% with operating margin -10.4% and ROIC -0.2%. Valuation is more restrained than many high-expectation growth names at price/sales 1.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PPJE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PPJE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PPJE Max Drawdown
-99.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PPJE and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$305.5K
-52.9% YoY
FY Net Income
$40.2K
-71.5% YoY
Free Cash Flow
$13.2M
-4.5% YoY
Revenue Growth
-6.4%
EPS Growth
+0.0%
Gross Margin
14.0%
Net Margin
-10.4%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 666K | 711K | 791K | 649K | 306K |
| Gross Profit | 104K | 216K | 301K | 280K | 102K |
| Operating Income | 8K | 75K | 141K | 144K | 40K |
| EBITDA | 8K | 75K | 370K | 144K | 246K |
| Net Income | 8K | 75K | 141K | 141K | 40K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 19K | 49K | 407K | 646K | 43K |
| Total Assets | 20M | 19M | 19M | 17M | 14M |
| Total Liabilities | 8M | 7M | 7M | 6M | 7M |
| Shareholder Equity | 13M | 12M | 12M | 11M | 7M |
| Total Debt | 3M | 3M | 3M | 3M | 2M |
| Net Debt | 3M | 3M | 2M | 2M | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
13M
-4.5% YoY
Capital Expenditures
3
+25.0% YoY
Free Cash Flow
13M
-4.5% YoY
Key ratios
Gross Margin
14.0%
Operating Margin
-10.4%
Net Margin
-10.4%
ROE
-0.2%
Debt / Equity
0.11x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.